Older and vulnerable people can be vaccinated against omicron sub-variants from October 18

Older and weak individuals will be vaccinated in opposition to omicron sub-variants from October 18

To inject a further dose of the vaccine in opposition to Covid-19, the Excessive Authority for Well being (HAS), in two opinions printed on Tuesday 20 September, beneficial the administration of one of many three vaccines tailored to the sub-variants of Omicron that have been just lately used. It’s authorized by the European Medicines Company (EMA).

Persevering with its earlier views, the unbiased authority that has directed the federal government in its vaccination technique for the reason that starting of the well being disaster has beneficial linking this new marketing campaign with the marketing campaign to fight seasonal influenza, which can begin on October 18.

As has already been the case for a number of months, this extra dose is meant for individuals vulnerable to creating acute sickness, that’s, all individuals aged 60 years or over, immunocompromised sufferers no matter their age, in addition to these round them, who’re pregnant. Ladies, kids and adolescents at excessive threat, and eventually professionals within the well being, medical and social sectors.

Learn additionally: This text is reserved for our subscribers COVID-19: Older and weak individuals will be vaccinated in opposition to Omicron sub-variants from October 18

Given the resumption of the epidemic that started two weeks in the past, the World Well being Meeting, nonetheless, recommends that folks at very excessive threat who didn’t obtain the second booster dose throughout the beneficial time-frame – three or six months relying on age and date of the final injection or damage – request a brand new injection now . Solely 30% of these over 60 have really acquired a second booster dose, and the injection fee is at its lowest for six months. “The unique vaccines are nonetheless efficient in opposition to extreme kinds. If you happen to’re too far out of your final reminder, do not wait an additional month. “,” warns Dominique Le Golodic, president of HAS.

Adapting to the present menace

Vaccines authorized in 1Verse and the Sept. 12 by EMA are these developed by Pfizer-BioNTech and Moderna; It is known as “bivalent” as a result of it targets each, like all vaccines given to date, the unique pressure of SARS-CoV-2 – generally known as the “Wuhan pressure” – and a sort of Omicron sub-variant. If two vaccines have been authorized by Pfizer-BioNTech, one concentrating on BA.1 and one concentrating on BA.4 and BA.5, Moderna, for its half, solely obtained a license for its BA.1-adapted vaccine.

These aren’t actually new vaccines, as a result of they use the identical know-how as those who have imposed themselves all over the world to struggle Covid-19: messenger RNA. It has merely been up to date to raised match the present menace, born of the Omicron household, which declined in France first with BA.1, then BA.2, then BA.4, and now, dominant BA.5. They are often in contrast on this to seasonal flu vaccines, that are up to date yearly to have in mind which viruses are probably to flow into throughout the winter.

You might have 47.83% of this text left to learn. The next is for subscribers solely.

Leave a Comment

Your email address will not be published.